Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Occult HBV infection in Chinese blood donors: role of N-glycosylation mutations and amino acid substitutions in S protein transmembrane domains.

Zhang L, Chang L, Laperche S, Ji H, Zhao J, Jiang X, Wang L, Candotti D.

Emerg Microbes Infect. 2019;8(1):1337-1346. doi: 10.1080/22221751.2019.1663130.

PMID:
31516090
2.

Human pegivirus-1 (HPgV-1) RNA prevalence and genotypes in volunteer blood donors from the Brazilian Amazon.

Slavov SN, Maraninchi Silveira R, Hespanhol MR, Sauvage V, Rodrigues ES, Fontanari Krause L, Bittencourt HT, Caro V, Laperche S, Covas DT, Kashima S.

Transfus Clin Biol. 2019 Jun 18. pii: S1246-7820(19)30070-9. doi: 10.1016/j.tracli.2019.06.005. [Epub ahead of print]

PMID:
31277987
3.

Serologic Prevalence of Ebola Virus in Equatorial Africa.

Steffen I, Lu K, Yamamoto LK, Hoff NA, Mulembakani P, Wemakoy EO, Muyembe-Tamfum JJ, Ndembi N, Brennan CA, Hackett J Jr, Stramer SL, Switzer WM, Saragosti S, Mbensa GO, Laperche S, Rimoin AW, Simmons G.

Emerg Infect Dis. 2019 May;25(5):911-918. doi: 10.3201/eid2505.180115.

4.

International Forum on Occult hepatitis B infection and transfusion safety.

Seed CR, Allain JP, Lozano M, Laperche S, Gallian P, Gross S, Kwon SY, Oh EY, Kim JN, Chua SS, Lam S, Ang AL, Tsoi WC, Hewitt PE, Davison KL, Tettmar K, O'Flaherty N, Boland F, Williams P, Pomeroy L, Wendel S, Fachini R, Scuracchio P, Carminato P, Fearon M, O'Brien SF, Delage G, Kiely P, Hoad V, Matsubayashi K, Satake M, Taira R, Stramer SL, Sauleda S, Bes M, Piron M, El Ekiaby M, Vermeulen M, Levičnik Stezinar S, Nograšek P, Jarvis LM, Petrik J, Charlewood R, Flanagan P, Grabarczyk P, Kopacz A, Łętowska M, Seifried E, Schmidt M.

Vox Sang. 2019 May;114(4):e1-e35. doi: 10.1111/vox.12743. Epub 2019 Apr 10. No abstract available.

PMID:
30972757
5.

Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.

Slavov SN, Rodrigues ES, Sauvage V, Caro V, Diefenbach CF, Zimmermann AM, Covas DT, Laperche S, Kashima S.

J Med Virol. 2019 Jul;91(7):1224-1231. doi: 10.1002/jmv.25453. Epub 2019 Mar 25.

PMID:
30851123
6.

International forum on Occult hepatitis B infection and transfusion safety.

Seed CR, Allain JP, Lozano M, Laperche S, Gallian P, Gross S, Kwon SY, Oh EY, Kim JN, Chua SS, Lam S, Ang AL, Tsoi WC, Hewitt PE, Davison K, Tettmar K, O'Flaherty N, Boland F, Williams P, Pomeroy L, Wendel S, Fachini R, Scuracchio PSP, Carminato P, Fearon M, O'Brien SF, Delages G, Kiely P, Hoad VC, Matsubayashi K, Satake M, Taira R, Stramer SL, Sauleda S, Bes M, Piron M, Ekiaby ME, Vermeulen M, Stezinar SL, Nograšek P, Jarvis LM, Petrik J, Charlewood R, Flanagan P, Grabarczyk P, Kopacz A, Łętowska M, Schmidt M, Seifried E.

Vox Sang. 2019 May;114(4):397-406. doi: 10.1111/vox.12744. Epub 2019 Feb 28. No abstract available.

PMID:
30818422
7.

Transfusion of HIV-infected blood products despite highly sensitive nucleic acid testing.

Cappy P, Barlet V, Lucas Q, Tinard X, Pillonel J, Gross S, Tiberghien P, Laperche S.

Transfusion. 2019 Jun;59(6):2046-2053. doi: 10.1111/trf.15203. Epub 2019 Feb 19.

PMID:
30784073
8.

High prevalence of cyclovirus Vietnam (CyCV-VN) in plasma samples from Madagascan healthy blood donors.

Sauvage V, Gomez J, Barray A, Vandenbogaert M, Boizeau L, Tagny CT, Rakoto O, Bizimana P, Guitteye H, Ciré BB, Soumana H, Tchomba JS, Caro V, Laperche S.

Infect Genet Evol. 2018 Dec;66:9-12. doi: 10.1016/j.meegid.2018.09.002. Epub 2018 Sep 7.

PMID:
30201501
9.

Updated characteristics of blood services, donors and blood products in 11 French-speaking African countries.

Tagny CT, Laperche S, Murphy EL; Francophone Africa Network for Transfusion Medicine Research.

Vox Sang. 2018 Oct;113(7):647-656. doi: 10.1111/vox.12702. Epub 2018 Aug 19.

PMID:
30125053
10.

Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose.

Candotti D, Assennato SM, Laperche S, Allain JP, Levicnik-Stezinar S.

Gut. 2019 Feb;68(2):313-321. doi: 10.1136/gutjnl-2018-316490. Epub 2018 Jun 29.

PMID:
29959168
11.

Transfusion-associated hazards: A revisit of their presentation.

Garraud O, Sut C, Haddad A, Tariket S, Aloui C, Laradi S, Hamzeh-Cognasse H, Bourlet T, Zeni F, Aubron C, Ozier Y, Laperche S, Peyrard T, Buffet P, Guyotat D, Tavernier E, Cognasse F, Pozzetto B, Andreu G.

Transfus Clin Biol. 2018 May;25(2):118-135. doi: 10.1016/j.tracli.2018.03.002. Epub 2018 Apr 4. Review.

PMID:
29625790
12.

Early MinION™ nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples.

Sauvage V, Boizeau L, Candotti D, Vandenbogaert M, Servant-Delmas A, Caro V, Laperche S.

PLoS One. 2018 Mar 22;13(3):e0194366. doi: 10.1371/journal.pone.0194366. eCollection 2018.

13.

Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures?

Candotti D, Laperche S.

Front Med (Lausanne). 2018 Feb 21;5:29. doi: 10.3389/fmed.2018.00029. eCollection 2018. Review.

14.

Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs.

Candotti D, Deng X, Li T, Laperche S, Sauvage V.

Ann Intern Med. 2018 Jan 16;168(2):158. doi: 10.7326/L17-0525. No abstract available. Erratum in: Ann Intern Med. 2018 Mar 6;168(5):384.

PMID:
29335727
15.

Fifteen years of Nucleic Acid Testing in France: Results and lessons.

Laperche S, Tiberghien P, Roche-Longin C, Pillonel J.

Transfus Clin Biol. 2017 Sep;24(3):182-188. doi: 10.1016/j.tracli.2017.06.020. Epub 2017 Jul 11. Review.

PMID:
28709845
16.

The potential of viral metagenomics in blood transfusion safety.

Sauvage V, Gomez J, Boizeau L, Laperche S.

Transfus Clin Biol. 2017 Sep;24(3):218-222. doi: 10.1016/j.tracli.2017.06.018. Epub 2017 Jul 8. Review.

PMID:
28694025
17.

Occult hepatitis B infection and transfusion-transmission risk.

Candotti D, Boizeau L, Laperche S.

Transfus Clin Biol. 2017 Sep;24(3):189-195. doi: 10.1016/j.tracli.2017.06.014. Epub 2017 Jun 30. Review.

PMID:
28673499
18.

Context and social perceptions of blood donation in donors found positive for human immunodeficiency virus in France.

Duquesnoy A, Danic B, Santos A, Martinaud C, Woimant G, Laperche S, Tiberghien P, Jauffret-Roustide M, Pillonel J; Steering Committee.

Transfusion. 2017 Sep;57(9):2240-2247. doi: 10.1111/trf.14187. Epub 2017 Jul 3.

PMID:
28671313
19.

Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.

Fourati S, Challine D, Poveda JD, Laperche S, Rallier S, Pawlotsky JM, Chevaliez S.

J Clin Virol. 2017 Jul;92:69-74. doi: 10.1016/j.jcv.2017.05.015. Epub 2017 May 17.

PMID:
28549336
20.

Risk factors for human immunodeficiency virus among blood donors in Cameroon: evidence for the design of an Africa-specific donor history questionnaire.

Tagny CT, Nguefack-Tsague G, Fopa D, Ashu C, Tante E, Ngo Balogog P, Donfack O, Mbanya D, Laperche S, Murphy E.

Transfusion. 2017 Aug;57(8):1912-1921. doi: 10.1111/trf.14140. Epub 2017 May 15.

PMID:
28508402
21.

Reducing risks of Transfusion-transmitted infections in a resource-limited hospital-based blood bank: the case of the Yaoundé University Teaching Hospital, Cameroon.

Tagny CT, Ndoumba A, Laperche S, Murphy E, Mbanya D.

ISBT Sci Ser. 2016 Aug;11(2):82-87. doi: 10.1111/voxs.12287. Epub 2016 Jul 19.

22.

Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and Japan.

Laperche S, Sauleda S, Piron M, Mühlbacher A, Schennach H, Schottstedt V, Queirós L, Uno N, Yanagihara K, Imdahl R, Hey A, Klinkicht M, Melchior W, Muench P, Watanabe T.

J Clin Microbiol. 2017 Jul;55(7):2180-2187. doi: 10.1128/JCM.00169-17. Epub 2017 May 3.

23.

The New Aptima HBV Quant Real-Time TMA Assay Accurately Quantifies Hepatitis B Virus DNA from Genotypes A to F.

Chevaliez S, Dauvillier C, Dubernet F, Poveda JD, Laperche S, Hézode C, Pawlotsky JM.

J Clin Microbiol. 2017 Apr;55(4):1211-1219. doi: 10.1128/JCM.02219-16. Epub 2017 Feb 15.

24.

Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples.

Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S.

J Clin Virol. 2017 Apr;89:14-21. doi: 10.1016/j.jcv.2017.02.001. Epub 2017 Feb 4.

PMID:
28189936
25.

17th International Haemovigilance Seminar: Paris (France), 9-11 March 2016.

Wood E, Bolton-Maggs P, Faber JC, Schipperus KL, Tomasulo P, Wiersum-Osselton J, Boyeldieu D, Cabaud JJ, Cartron JP, Daban JL, Daurat G, Djoudi R, Faurey D, Folléa G, Gouezec H, Garraud O, Laperche S, Lassale B, Lefort C, Muller JY, Oubouzar N, Pirenne F, Py JY, Renaudier P, Roche C, Sailliol A, Tiberghien P, Tinard X.

Blood Transfus. 2016 Mar 2:s1-s80. doi: 10.2450/2016.S1. [Epub ahead of print] No abstract available.

26.

The infectious risks in blood transfusion as of today - A no black and white situation.

Garraud O, Filho LA, Laperche S, Tayou-Tagny C, Pozzetto B.

Presse Med. 2016 Jul-Aug;45(7-8 Pt 2):e303-11. doi: 10.1016/j.lpm.2016.06.022. Epub 2016 Jul 27. Review.

PMID:
27476017
27.

Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: Prevalence of quasi-subgenotype A3, genotype E, and mixed infections.

Candotti D, Diarra B, Bisseye C, Tao I, Pham Quang K, Sanou M, Laperche S, Sanogo R, Allain JP, Simpore J.

J Med Virol. 2016 Dec;88(12):2145-2156. doi: 10.1002/jmv.24589. Epub 2016 Jun 14.

PMID:
27253483
28.

Viral metagenomics applied to blood donors and recipients at high risk for blood-borne infections.

Sauvage V, Laperche S, Cheval J, Muth E, Dubois M, Boizeau L, Hébert C, Lionnet F, Lefrère JJ, Eloit M.

Blood Transfus. 2016 Sep;14(5):400-7. doi: 10.2450/2016.0160-15. Epub 2016 Mar 16.

29.

New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France.

Servant-Delmas A, Abravanel F, Lefrère JJ, Lionnet F, Hamon C, Izopet J, Laperche S.

J Viral Hepat. 2016 Jul;23(7):569-75. doi: 10.1111/jvh.12531. Epub 2016 Mar 18.

PMID:
26990022
30.

Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care.

Chevaliez S, Poiteau L, Rosa I, Soulier A, Roudot-Thoraval F, Laperche S, Hézode C, Pawlotsky JM.

Clin Microbiol Infect. 2016 May;22(5):459.e1-6. doi: 10.1016/j.cmi.2016.01.009. Epub 2016 Jan 22.

31.

Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow.

Garraud O, Heshmati F, Pozzetto B, Lefrere F, Girot R, Saillol A, Laperche S.

Transfus Clin Biol. 2016 Feb;23(1):39-44. doi: 10.1016/j.tracli.2015.12.003. Epub 2016 Jan 6. Review.

PMID:
26775794
32.

[Jean-Jacques Lefrère: A miscarried ambition for blood safety in francophone Africa].

Tayou Tagny C, Laperche S, Murphy E; Groupe de recherches transfusionnelles en Afrique francophone.

Transfus Clin Biol. 2016 Feb;23(1):45-8. doi: 10.1016/j.tracli.2015.12.006. Epub 2016 Jan 4. French.

PMID:
26762688
33.

[Jean-Jacques Lefrère, an inspired and inspiring physician on blood safety service].

Laperche S, Garraud O.

Transfus Clin Biol. 2016 Feb;23(1):2-4. doi: 10.1016/j.tracli.2015.11.005. Epub 2015 Dec 18. French. No abstract available.

PMID:
26709237
34.

Improving platelet transfusion safety: biomedical and technical considerations.

Garraud O, Cognasse F, Tissot JD, Chavarin P, Laperche S, Morel P, Lefrère JJ, Pozzetto B, Lozano M, Blumberg N, Osselaer JC.

Blood Transfus. 2016 Mar;14(2):109-22. doi: 10.2450/2015.0042-15. Epub 2015 Nov 16. Review.

35.

Screening for transfusion transmissible infections using rapid diagnostic tests in Africa: a potential hazard to blood safety?

Prugger C, Laperche S, Murphy EL, Bloch EM, Kaidarova Z, Tafflet M, Lefrère JJ, Jouven X.

Vox Sang. 2016 Feb;110(2):196-8. doi: 10.1111/vox.12327. Epub 2015 Dec 8.

36.

Comparative Performance of Three Rapid HBsAg Assays for Detection of HBs Diagnostic Escape Mutants in Clinical Samples.

Servant-Delmas A, Ly TD, Hamon C, Houdah AK, Laperche S.

J Clin Microbiol. 2015 Dec;53(12):3954-5. doi: 10.1128/JCM.02117-15. Epub 2015 Sep 16. No abstract available.

37.

Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples.

Laperche S, Nübling CM, Stramer SL, Brojer E, Grabarczyk P, Yoshizawa H, Kalibatas V, El Elkyabi M, Moftah F, Girault A, van Drimmelen H, Busch MP, Lelie N.

Transfusion. 2015 Oct;55(10):2489-98. doi: 10.1111/trf.13179. Epub 2015 May 27.

38.

Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.

El Ekiaby M, Moftah F, Goubran H, van Drimmelen H, LaPerche S, Kleinman S, Busch M, Lelie N.

Transfusion. 2015 Jun;55(6):1186-94. doi: 10.1111/trf.13061. Epub 2015 Mar 13.

PMID:
25766141
39.

[Blood transfusion: control of infectious risks].

Laperche S, Lefrère JJ, Morel P, Pouchol E, Pozzetto B.

Presse Med. 2015 Feb;44(2):189-99. doi: 10.1016/j.lpm.2014.06.034. Epub 2014 Dec 26. Review. French.

PMID:
25547992
40.

No evidence of Marseillevirus-like virus presence in blood donors and recipients of multiple blood transfusions.

Sauvage V, Livartowski A, Boizeau L, Servant-Delmas A, Lionnet F, Lefrère JJ, Laperche S.

J Infect Dis. 2014 Dec 15;210(12):2017-8. doi: 10.1093/infdis/jiu443. Epub 2014 Sep 28. No abstract available.

PMID:
25267981
41.

[Assessment of a transfusion emergent risk: the case of HEV].

Pillonel J, Gallian P, Sommen C, Couturier E, Piquet Y, Djoudi R, Laperche S; Comité de Pilotage de la Surveillance Épidémiologique des Donneurs de Sang.

Transfus Clin Biol. 2014 Nov;21(4-5):162-6. doi: 10.1016/j.tracli.2014.07.004. Epub 2014 Sep 27. French.

PMID:
25267205
42.

[Relevance of safety measures to avoid HTLV transmission by transfusion in 2014].

Laperche S, Pillonel J.

Transfus Clin Biol. 2014 Nov;21(4-5):167-72. doi: 10.1016/j.tracli.2014.07.003. Epub 2014 Sep 27. French.

PMID:
25267203
43.

Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus.

Pivert A, Servant-Delmas A, Lunel-Fabiani F, Le Guillou-Guillemette H, Laperche S, Ducancelle A.

J Med Virol. 2015 Mar;87(3):529-35. doi: 10.1002/jmv.24064. Epub 2014 Aug 29.

PMID:
25170961
44.

Safety measures to prevent hepatitis E virus transmission by blood transfusion.

Laperche S, Izopet J, Lefrère JJ.

Transfusion. 2014 Aug;54(8):2134-5. doi: 10.1111/trf.12735. No abstract available.

PMID:
25130335
45.

A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countries.

Bloch EM, Shah A, Kaidarova Z, Laperche S, Lefrere JJ, van Hasselt J, Zacharias P, Murphy EL; Anglophone Africa Transfusion Research Group.

Vox Sang. 2014 Nov;107(4):333-42. doi: 10.1111/vox.12182. Epub 2014 Jul 23.

46.

Could droplet digital PCR be used instead of real-time PCR for quantitative detection of the hepatitis B virus genome in plasma?

Boizeau L, Laperche S, Désiré N, Jourdain C, Thibault V, Servant-Delmas A.

J Clin Microbiol. 2014 Sep;52(9):3497-8. doi: 10.1128/JCM.01306-14. Epub 2014 Jul 2. No abstract available.

47.

Human parvovirus 4 infection in low- and high-risk French individuals.

Servant-Delmas A, Laperche S, Lionnet F, Sharp C, Simmonds P, Lefrère JJ.

Transfusion. 2014 Mar;54(3):744-5. doi: 10.1111/trf.12512. No abstract available.

PMID:
24617588
48.

Serological and molecular diagnosis of hepatitis delta virus infection: results of a French national quality control study.

Brichler S, Le Gal F, Neri-Pinto F, Mansour W, Roulot D, Laperche S, Gordien E.

J Clin Microbiol. 2014 May;52(5):1694-7. doi: 10.1128/JCM.03521-13. Epub 2014 Feb 12.

49.

Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test.

Tagny CT, Mbanya D, Murphy EL, Lefrère JJ, Laperche S.

J Virol Methods. 2014 Apr;199:119-23. doi: 10.1016/j.jviromet.2014.01.002. Epub 2014 Jan 30.

50.

Increasing prevalence of HDV/HBV infection over 15 years in France.

Servant-Delmas A, Le Gal F, Gallian P, Gordien E, Laperche S.

J Clin Virol. 2014 Feb;59(2):126-8. doi: 10.1016/j.jcv.2013.11.016. Epub 2013 Dec 7.

PMID:
24365475

Supplemental Content

Loading ...
Support Center